Annual EBITDA:
-$157.24M-$54.76M(-53.43%)Summary
- As of today, GPCR annual EBITDA is -$157.24 million, with the most recent change of -$54.76 million (-53.43%) on December 31, 2024.
- During the last 3 years, GPCR annual EBITDA has fallen by -$119.61 million (-317.91%).
- GPCR annual EBITDA is now -888.53% below its all-time high of -$15.91 million, reached on December 1, 2020.
Performance
GPCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$72.91M-$3.06M(-4.38%)Summary
- As of today, GPCR quarterly EBITDA is -$72.91 million, with the most recent change of -$3.06 million (-4.38%) on September 30, 2025.
- Over the past year, GPCR quarterly EBITDA has dropped by -$26.96 million (-58.68%).
- GPCR quarterly EBITDA is now -470.17% below its all-time high of -$12.79 million, reached on December 31, 2022.
Performance
GPCR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$243.48M-$26.96M(-12.45%)Summary
- As of today, GPCR TTM EBITDA is -$243.48 million, with the most recent change of -$26.96 million (-12.45%) on September 30, 2025.
- Over the past year, GPCR TTM EBITDA has dropped by -$102.25 million (-72.41%).
- GPCR TTM EBITDA is now -1748.97% below its all-time high of -$13.17 million, reached on December 1, 2021.
Performance
GPCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GPCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -53.4% | -58.7% | -72.4% |
| 3Y3 Years | -317.9% | -470.2% | -518.9% |
| 5Y5 Years | -888.5% | -453.6% | -1749.0% |
GPCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -317.9% | at low | -470.2% | at low | -518.9% | at low |
| 5Y | 5-Year | -888.5% | at low | -470.2% | at low | -1749.0% | at low |
| All-Time | All-Time | -888.5% | at low | -470.2% | at low | -1749.0% | at low |
GPCR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$72.91M(-4.4%) | -$243.48M(-12.5%) |
| Jun 2025 | - | -$69.84M(-25.4%) | -$216.52M(-20.5%) |
| Mar 2025 | - | -$55.70M(-23.7%) | -$179.72M(-15.7%) |
| Dec 2024 | -$157.24M(-53.4%) | -$45.02M(+2.0%) | -$155.32M(-10.0%) |
| Sep 2024 | - | -$45.95M(-39.0%) | -$141.22M(-16.6%) |
| Jun 2024 | - | -$33.05M(-5.6%) | -$121.07M(-6.6%) |
| Mar 2024 | - | -$31.30M(-1.2%) | -$113.57M(-11.6%) |
| Dec 2023 | -$102.48M | -$30.93M(-19.9%) | -$101.73M(-21.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$25.80M(-1.0%) | -$83.59M(-44.6%) |
| Jun 2023 | - | -$25.55M(-31.3%) | -$57.79M(-25.7%) |
| Mar 2023 | - | -$19.46M(-52.2%) | -$45.98M(-16.9%) |
| Dec 2022 | -$52.28M(-39.0%) | -$12.79M(+6.9%) | -$39.34M(+1.0%) |
| Jun 2022 | - | -$13.74M(-7.2%) | -$39.72M(-52.9%) |
| Mar 2022 | - | -$12.82M(+2.7%) | -$25.99M(-97.3%) |
| Dec 2021 | -$37.62M(-136.5%) | - | - |
| Dec 2021 | - | -$13.17M | -$13.17M |
| Dec 2020 | -$15.91M | - | - |
FAQ
- What is Structure Therapeutics Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. annual EBITDA year-on-year change?
- What is Structure Therapeutics Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. quarterly EBITDA year-on-year change?
- What is Structure Therapeutics Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. TTM EBITDA year-on-year change?
What is Structure Therapeutics Inc. annual EBITDA?
The current annual EBITDA of GPCR is -$157.24M
What is the all-time high annual EBITDA for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high annual EBITDA is -$15.91M
What is Structure Therapeutics Inc. annual EBITDA year-on-year change?
Over the past year, GPCR annual EBITDA has changed by -$54.76M (-53.43%)
What is Structure Therapeutics Inc. quarterly EBITDA?
The current quarterly EBITDA of GPCR is -$72.91M
What is the all-time high quarterly EBITDA for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high quarterly EBITDA is -$12.79M
What is Structure Therapeutics Inc. quarterly EBITDA year-on-year change?
Over the past year, GPCR quarterly EBITDA has changed by -$26.96M (-58.68%)
What is Structure Therapeutics Inc. TTM EBITDA?
The current TTM EBITDA of GPCR is -$243.48M
What is the all-time high TTM EBITDA for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high TTM EBITDA is -$13.17M
What is Structure Therapeutics Inc. TTM EBITDA year-on-year change?
Over the past year, GPCR TTM EBITDA has changed by -$102.25M (-72.41%)